Gf Fund Management Co. Ltd. Argenx Se Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Argenx Se stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 826 shares of ARGX stock, worth $532,885. This represents 0.01% of its overall portfolio holdings.
Number of Shares
826
Previous 677
22.01%
Holding current value
$532,885
Previous $416 Million
17.42%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
444Shares Held
29.1MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.56 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.98 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.49 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.15 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$799 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.7B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...